High levels of the adhesion molecule CD44 on leukemic cells generate acute myeloid leukemia relapse after withdrawal of the initial transforming event
Open Access
- 30 November 2010
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 25 (3) , 515-526
Abstract
Multiple genetic hits are detected in patients with acute myeloid leukemia (AML). To investigate this further, we developed a tetracycline-inducible mouse model of AML, in which the initial transforming event, overexpression of HOXA10, can be eliminated. Continuous overexpression of HOXA10 is required to generate AML in primary recipient mice, but is not essential for maintenance of the leukemia. Transplantation of AML to secondary recipients showed that in established leukemias, ~80% of the leukemia-initiating cells (LICs) in bone marrow stopped proliferating upon withdrawal of HOXA10 overexpression. However, the population of LICs in primary recipients is heterogeneous, as ~20% of the LICs induce leukemia in secondary recipients despite elimination of HOXA10-induced overexpression. Intrinsic genetic activation of several proto-oncogenes was observed in leukemic cells resistant to inactivation of the initial transformation event. Interestingly, high levels of the adhesion molecule CD44 on leukemic cells are essential to generate leukemia after removal of the primary event. This suggests that extrinsic niche-dependent factors are also involved in the host-dependent outgrowth of leukemias after withdrawal of HOXA10 overexpression event that initiates the leukemia.Keywords
This publication has 49 references indexed in Scilit:
- Matrix Metalloproteinase-9 Promotes Chronic Lymphocytic Leukemia B Cell Survival through Its Hemopexin DomainCancer Cell, 2010
- Acute myeloid leukemia induced by MLL-ENL is cured by oncogene ablation despite acquisition of complex genetic abnormalitiesBlood, 2009
- HOXA9 is required for survival in human MLL-rearranged acute leukemiasBlood, 2009
- A retroviral mutagenesis screen reveals strong cooperation between Bcl11a overexpression and loss of the Nf1 tumor suppressor geneBlood, 2009
- HOX expression patterns identify a common signature for favorable AMLLeukemia, 2008
- AML1–ETO meets JAK2: clinical evidence for the two hit model of leukemogenesis from a myeloproliferative syndrome progressing to acute myeloid leukemiaLeukemia, 2007
- Commonly dysregulated genes in murine APL cellsBlood, 2006
- Significance of Murine Retroviral Mutagenesis for Identification of Disease Genes in Human Acute Myeloid LeukemiaCancer Research, 2006
- Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesisBlood, 2005
- Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1bThe EMBO Journal, 1998